Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,914,813
+$5,283,490 QoQ
Shares Held
9,100
+73.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#1,211
of 4,605 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$43,779,198
PutShares
36,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $56,332,097 across 7 Drug Manufacturers - General names. LLY ranks #3 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,000 | $15,238,200 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
100,000 | $12,634,000 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
9,100 | $10,914,813 | |
| 4 | AZN |
Astrazeneca PLC
|
34,800 | $6,598,776 | |
| 5 | NVO |
Novo Nordisk A S
|
103,132 | $4,944,148 | |
| 6 | BIIB |
Biogen Inc.
|
21,000 | $4,537,260 | |
| 7 | MRK |
Merck & Co., Inc.
|
11,400 | $1,464,900 |
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,914,813 | 9,100 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $43,779,198 | 36,500 | Put | Sole | 2026-08-14 | |
| 2025-12-31 | $5,631,323 | 5,240 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $64,373,337 | 59,900 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $49,757,688 | 46,300 | Call | Sole | 2026-02-17 | |
| 2025-06-30 | $14,966,976 | 19,200 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $4,131,509 | 5,300 | Shares | Sole | 2025-08-14 | |
| 2023-12-31 | $11,658,400 | 20,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $6,820,164 | 11,700 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,668,340 | 18,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $8,254,048 | 17,600 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $12,878,250 | 37,500 | Call | Sole | 2023-05-15 | |
| 2022-09-30 | $76,633 | 237 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $11,866,945 | 36,700 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $5,658,625 | 17,500 | Call | Sole | 2022-11-14 | |
| 2021-12-31 | $24,859,800 | 90,000 | Call | Sole | 2022-02-11 | |
| 2021-03-31 | $2,241,840 | 12,000 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||